Global Veterinary Medicine Market Research Report—Forecast till 2027

Global Veterinary Medicine Market Research Report—Forecast till 2027

$4450 – $6250

Global Veterinary Medicine Market is anticipated to witness a healthy CAGR of 5.57% during the review period of 2020 to 2027. The rising rates of pet ownership, increasing chronic diseases, and growing consumption of meat are expected to create many growth opportunities for the global market.

SKU: MRFR210136 Category: Tags: , , , , , , , , , ,

Description

Global Veterinary Medicine Market Research Report—Forecast till 2027

Market Synopsis
Global Veterinary Medicine Market is anticipated to witness a healthy CAGR of 5.57% during the review period of 2020 to 2027. The rising rates of pet ownership, increasing chronic diseases, and growing consumption of meat are expected to create many growth opportunities for the global market. Apart from meat utilization, the dairy items request has likewise flooded. Expanding meat and dairy utilization request the security of domesticated animals and consistent checking of their wellbeing to capture the spread of illnesses from creatures to people. Amid the developing meat utilization, the emphasis on improving the wellbeing of new meat has expanded.
The global veterinary medicine market is expected to register a significant market owing to the largest value at USD 28,012.73 Million in 2019. The increasing predominance of diseases in animals poses a serious threat to food security. Climate change and globalization are the major reasons attributing to the rise in diseases among animals. Moreover, the increase in the number of pet ownerships is propelling the requirement for better care of companion animals, driving the overall expenditure on pets.
Market Segmentation
Global Veterinary Medicine Market has been classified into Animal Type, Product, Route of Administration, and Distribution Channel.
In terms of animal type, the global market has been divided into domesticated and companion.
In terms of product segments, the market is segmented into drugs and vaccines. By the route of administration, the market is categorized into oral, parental, and others. Based on the distribution channel, the market is divided into veterinary hospitals & clinics, retail stores, and online pharmacies.
Regional Analysis
Geographically, the Global Veterinary Medicine Market has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa.
The Americas is likely to contribute the largest market owing to the increase in companion animal ownership and the rising prevalence of animal diseases in the region. As per Atlas Dental, a total of 69,075 dental operations were performed in German hospitals in 2017. Additionally, the global market growth is attributed to the increasing population of pets and livestock with a high number of veterinary practices.
Europe contributes to the second-largest market in the global veterinary medicine market during the review period. The regional market is driven by the increasing prevalence of diseases, new product approvals, and the existence of developed veterinary healthcare infrastructure.
Asia-Pacific is expected to attain the fastest-growing market during the review period. The regional market is driven by the increasing penetration of the veterinary sector, the increase in the number of private veterinary clinics, growing awareness about animal welfare, and government campaigns for the welfare of pet animals in China, Japan, India, South Korea, and Australia.
The veterinary medicine market in Middle East & Africa is anticipated to register steady growth during the forecast period owing to the presence of developing countries in the region.
Major Players
The Key Players in the Global Veterinary Medicine Market are Boehringer Ingelheim, Ceva, Chanelle Pharma Group, Dechra Pharmaceuticals plc, Elanco, Merck Animal Health, Norbrook Laboratories, Vetoquinol S.A., Bayer AG, and Zoetis.

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENT 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 SCOPE OF THE STUDY 15 2.2 RESEARCH OBJECTIVE 15 2.3 MARKET STRUCTURE 15 2.4 ASSUMPTIONS & LIMITATIONS 16 3 RESEARCH METHODOLOGY 3.1 DATA MINING 17 3.2 SECONDARY RESEARCH 18 3.3 PRIMARY RESEARCH 19 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 20 3.5 FORECASTING TECHNIQUES 20 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22 3.6.1 BOTTOM-UP APPROACH 23 3.6.2 TOP-DOWN APPROACH 23 3.7 DATA TRIANGULATION 24 3.8 VALIDATION 24 4 MARKET DYNAMICS 4.1 OVERVIEW 25 4.2 DRIVERS 26 4.2.1 GROWING RATES OF PET OWNERSHIP 26 4.2.2 RISING ZOONOTIC & CHRONIC DISEASES ANIMALS 26 4.2.3 INCREASING MEAT CONSUMPTION ATTRACTING MANDATORY VACCINATION 26 4.3 RESTRAINT 27 4.3.1 SHORTAGE OF VETERINARIANS 27 4.3.2 STRINGENT REGULATORY GUIDELINES PERTAINING TO VACCINES APPROVAL FOR ANIMALS 27 4.4 OPPORTUNITY 28 4.4.1 INCREASING INVESTMENT IN VETERINARY HOSPITALS 28 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 29 5.1.1 R&D 30 5.1.2 MANUFACTURING 30 5.1.3 DISTRIBUTION & SALES 30 5.1.4 POST-SALES REVIEW/MONITORING 30 5.2 PORTER'S FIVE FORCES MODEL 31 5.2.1 THREAT OF NEW ENTRANTS 31 5.2.2 BARGAINING POWER OF SUPPLIERS 32 5.2.3 THREAT OF SUBSTITUTES 32 5.2.4 BARGAINING POWER OF BUYERS 32 5.2.5 INTENSITY OF RIVALRY 32 5.3 IMPACT OF COVID-19 32 5.3.1 OVERVIEW 32 5.3.2 IMPACT ON MEAT CONSUMPTION 33 5.3.3 IMPACT ON VETERINARY MEDICINE MARKET 33 6 GLOBAL VETERINARY MEDICINE MARKET, BY ANIMAL TYPE 6.1 OVERVIEW 34 6.2 DOMESTICATED 35 6.3 COMPANION 35 7 GLOBAL VETERINARY MEDICINE MARKET, BY PRODUCT 7.1 OVERVIEW 37 7.2 DRUG 38 7.3 VACCINES 39 8 GLOBAL VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION 8.1 OVERVIEW 40 8.2 ORAL 41 8.3 PARENTERAL 41 8.4 OTHERS 42 9 GLOBAL VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL 9.1 OVERVIEW 43 9.2 VETERINARY HOSPITALS & CLINICS 44 9.3 RETAIL STORES 44 9.4 ONLINE PHARMACIES 45 10 GLOBAL VETERINARY MEDICINE MARKET, BY REGION 10.1 OVERVIEW 46 10.2 AMERICAS 48 10.2.1 NORTH AMERICA 50 10.2.1.1 US 52 10.2.1.2 CANADA 53 10.2.2 LATIN AMERICA 54 10.3 EUROPE 56 10.3.1 WESTERN EUROPE 58 10.3.1.1 GERMANY 60 10.3.1.2 UK 61 10.3.1.3 FRANCE 62 10.3.1.4 ITALY 63 10.3.1.5 SPAIN 64 10.3.1.6 REST OF WESTERN EUROPE 65 10.3.2 EASTERN EUROPE 67 10.4 ASIA-PACIFIC 69 10.4.1 CHINA 71 10.4.2 JAPAN 72 10.4.3 INDIA 73 10.4.4 AUSTRALIA 74 10.4.5 SOUTH KOREA 75 10.4.6 REST OF ASIA-PACIFIC 76 10.5 MIDDLE EAST & AFRICA 78 10.5.1 SAUDI ARABIA 80 10.5.2 UNITED ARAB EMIRATES 81 10.5.3 OMAN 83 10.5.4 KUWAIT 84 10.5.5 QATAR 85 10.5.6 REST OF THE MIDDLE EAST & AFRICA 86 11 COMPETITIVE LANDSCAPE 11.1 OVERVIEW 88 11.2 COMPETITIVE BENCHMARKING 89 11.3 GLOBAL VETERINARY MEDICINE MARKET: COMPANY RANKING 90 11.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 91 11.5 MAJOR GROWTH STRATEGY IN THE GLOBAL VETERINARY MEDICINE MARKET 91 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 92 11.6.1 NEW PRODUCT LAUNCHES 92 11.6.2 PARTNERSHIPS/AGREEMENTS 92 11.6.3 EXPANSIONS 93 11.6.4 ACQUISITIONS 93 11.7 FINANCIAL MATRIX 94 12 COMPANY PROFILES 12.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 96 12.1.1 COMPANY OVERVIEW 96 12.1.2 FINANCIAL OVERVIEW 97 12.1.3 PRODUCTS/SERVICES OFFERED 97 12.1.4 KEY DEVELOPMENTS 99 12.1.5 SWOT ANALYSIS 99 12.1.6 KEY STRATEGIES 100 12.2 CEVA 101 12.2.1 COMPANY OVERVIEW 101 12.2.2 FINANCIAL OVERVIEW 101 12.2.3 PRODUCTS/SERVICES OFFERED 102 12.2.4 KEY DEVELOPMENTS 102 12.2.5 SWOT ANALYSIS 103 12.2.6 KEY STRATEGIES 103 12.3 ZOETIS 104 12.3.1 COMPANY OVERVIEW 104 12.3.2 FINANCIAL OVERVIEW 104 12.3.3 PRODUCTS/SERVICES OFFERED 105 12.3.4 KEY DEVELOPMENTS 107 12.3.5 SWOT ANALYSIS 107 12.3.6 KEY STRATEGIES 107 12.4 MERCK ANIMAL HEALTH 108 12.4.1 COMPANY OVERVIEW 108 12.4.2 FINANCIAL OVERVIEW 109 12.4.3 PRODUCTS/SERVICES OFFERED 110 12.4.4 KEY DEVELOPMENTS 111 12.4.5 SWOT ANALYSIS 112 12.4.6 KEY STRATEGIES 112 12.5 CHANELLE PHARMA GROUP 113 12.5.1 COMPANY OVERVIEW 113 12.5.2 FINANCIAL OVERVIEW 113 12.5.3 PRODUCTS/SERVICES OFFERED 113 12.5.4 KEY DEVELOPMENTS 115 12.5.5 SWOT ANALYSIS 115 12.5.6 KEY STRATEGIES 115 12.6 ELANCO 116 12.6.1 COMPANY OVERVIEW 116 12.6.2 FINANCIAL OVERVIEW 117 12.6.3 PRODUCTS/SERVICES OFFERED 118 12.6.4 KEY DEVELOPMENTS 119 12.6.5 SWOT ANALYSIS 120 12.6.6 KEY STRATEGIES 120 12.7 DECHRA PHARMACEUTICALS PLC 121 12.7.1 COMPANY OVERVIEW 121 12.7.2 FINANCIAL OVERVIEW 121 12.7.3 PRODUCTS/SERVICES OFFERED 122 12.7.4 KEY DEVELOPMENTS 123 12.7.5 SWOT ANALYSIS 123 12.7.6 KEY STRATEGIES 123 12.8 BAYER AG 124 12.8.1 COMPANY OVERVIEW 124 12.8.2 FINANCIAL OVERVIEW 124 12.8.3 PRODUCTS/SERVICES OFFERED 125 12.8.4 KEY DEVELOPMENTS 126 12.8.5 SWOT ANALYSIS 127 12.8.6 KEY STRATEGIES 127 12.9 VETOQUINOL SA. 128 12.9.1 COMPANY OVERVIEW 128 12.9.2 FINANCIAL OVERVIEW 128 12.9.3 PRODUCTS/SERVICES OFFERED 129 12.9.4 KEY DEVELOPMENTS 131 12.9.5 SWOT ANALYSIS 132 12.9.6 KEY STRATEGIES 132 12.10 NORBROOK LABORATORIES 133 12.10.1 COMPANY OVERVIEW 133 12.10.2 FINANCIAL OVERVIEW 133 12.10.3 PRODUCTS/SERVICES OFFERED 133 12.10.4 KEY DEVELOPMENTS 135 12.10.5 SWOT ANALYSIS 135 12.10.6 KEY STRATEGIES 136 13 APPENDIX 13.1 REFERENCES 137 13.2 RELATED REPORTS 138

Related products